Cargando…

The Genetically Modified Polysialylated Form of Neural Cell Adhesion Molecule-Positive Cells for Potential Treatment of X-Linked Adrenoleukodystrophy

PURPOSE: Cell transplantation of myelin-producing exogenous cells is being extensively explored as a means of remyelinating axons in X-linked adrenoleukodystrophy. We determined whether 3,3',5-Triiodo-L-thyronine (T3) overexpresses the ABCD2 gene in the polysialylated (PSA) form of neural cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Jang, Jiho, Kim, Han-Soo, Kang, Joon Won, Kang, Hoon-Chul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Yonsei University College of Medicine 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3521252/
https://www.ncbi.nlm.nih.gov/pubmed/23225827
http://dx.doi.org/10.3349/ymj.2013.54.1.246
_version_ 1782252915051724800
author Jang, Jiho
Kim, Han-Soo
Kang, Joon Won
Kang, Hoon-Chul
author_facet Jang, Jiho
Kim, Han-Soo
Kang, Joon Won
Kang, Hoon-Chul
author_sort Jang, Jiho
collection PubMed
description PURPOSE: Cell transplantation of myelin-producing exogenous cells is being extensively explored as a means of remyelinating axons in X-linked adrenoleukodystrophy. We determined whether 3,3',5-Triiodo-L-thyronine (T3) overexpresses the ABCD2 gene in the polysialylated (PSA) form of neural cell adhesion molecule (NCAM)-positive cells and promotes cell proliferation and favors oligodendrocyte lineage differentiation. MATERIALS AND METHODS: PSA-NCAM(+) cells from newborn Sprague-Dawley rats were grown for five days on uncoated dishes in defined medium with or without supplementation of basic fibroblast growth factor (bFGF) and/or T3. Then, PSA-NCAM(+) spheres were prepared in single cells and transferred to polyornithine/fibronectin-coated glass coverslips for five days to determine the fate of the cells according to the supplementation of these molecules. T3 responsiveness of ABCD2 was analyzed using real-time quantitative polymerase chain reaction, the growth and fate of cells were determined using 5-bromo-2-deoxyuridine incorporation and immunocytochemistry, respectively. RESULTS: Results demonstrated that T3 induces overexpression of the ABCD2 gene in PSA-NCAM(+) cells, and can enhance PSA-NCAM(+) cell growth in the presence of bFGF, favoring an oligodendrocyte fate. CONCLUSION: These results may provide new insights into investigation of PSA-NCAM(+) cells for therapeutic application to X-linked adrenoleukodystrophy.
format Online
Article
Text
id pubmed-3521252
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Yonsei University College of Medicine
record_format MEDLINE/PubMed
spelling pubmed-35212522013-01-01 The Genetically Modified Polysialylated Form of Neural Cell Adhesion Molecule-Positive Cells for Potential Treatment of X-Linked Adrenoleukodystrophy Jang, Jiho Kim, Han-Soo Kang, Joon Won Kang, Hoon-Chul Yonsei Med J Original Article PURPOSE: Cell transplantation of myelin-producing exogenous cells is being extensively explored as a means of remyelinating axons in X-linked adrenoleukodystrophy. We determined whether 3,3',5-Triiodo-L-thyronine (T3) overexpresses the ABCD2 gene in the polysialylated (PSA) form of neural cell adhesion molecule (NCAM)-positive cells and promotes cell proliferation and favors oligodendrocyte lineage differentiation. MATERIALS AND METHODS: PSA-NCAM(+) cells from newborn Sprague-Dawley rats were grown for five days on uncoated dishes in defined medium with or without supplementation of basic fibroblast growth factor (bFGF) and/or T3. Then, PSA-NCAM(+) spheres were prepared in single cells and transferred to polyornithine/fibronectin-coated glass coverslips for five days to determine the fate of the cells according to the supplementation of these molecules. T3 responsiveness of ABCD2 was analyzed using real-time quantitative polymerase chain reaction, the growth and fate of cells were determined using 5-bromo-2-deoxyuridine incorporation and immunocytochemistry, respectively. RESULTS: Results demonstrated that T3 induces overexpression of the ABCD2 gene in PSA-NCAM(+) cells, and can enhance PSA-NCAM(+) cell growth in the presence of bFGF, favoring an oligodendrocyte fate. CONCLUSION: These results may provide new insights into investigation of PSA-NCAM(+) cells for therapeutic application to X-linked adrenoleukodystrophy. Yonsei University College of Medicine 2013-01-01 2012-11-28 /pmc/articles/PMC3521252/ /pubmed/23225827 http://dx.doi.org/10.3349/ymj.2013.54.1.246 Text en © Copyright: Yonsei University College of Medicine 2013 http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Jang, Jiho
Kim, Han-Soo
Kang, Joon Won
Kang, Hoon-Chul
The Genetically Modified Polysialylated Form of Neural Cell Adhesion Molecule-Positive Cells for Potential Treatment of X-Linked Adrenoleukodystrophy
title The Genetically Modified Polysialylated Form of Neural Cell Adhesion Molecule-Positive Cells for Potential Treatment of X-Linked Adrenoleukodystrophy
title_full The Genetically Modified Polysialylated Form of Neural Cell Adhesion Molecule-Positive Cells for Potential Treatment of X-Linked Adrenoleukodystrophy
title_fullStr The Genetically Modified Polysialylated Form of Neural Cell Adhesion Molecule-Positive Cells for Potential Treatment of X-Linked Adrenoleukodystrophy
title_full_unstemmed The Genetically Modified Polysialylated Form of Neural Cell Adhesion Molecule-Positive Cells for Potential Treatment of X-Linked Adrenoleukodystrophy
title_short The Genetically Modified Polysialylated Form of Neural Cell Adhesion Molecule-Positive Cells for Potential Treatment of X-Linked Adrenoleukodystrophy
title_sort genetically modified polysialylated form of neural cell adhesion molecule-positive cells for potential treatment of x-linked adrenoleukodystrophy
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3521252/
https://www.ncbi.nlm.nih.gov/pubmed/23225827
http://dx.doi.org/10.3349/ymj.2013.54.1.246
work_keys_str_mv AT jangjiho thegeneticallymodifiedpolysialylatedformofneuralcelladhesionmoleculepositivecellsforpotentialtreatmentofxlinkedadrenoleukodystrophy
AT kimhansoo thegeneticallymodifiedpolysialylatedformofneuralcelladhesionmoleculepositivecellsforpotentialtreatmentofxlinkedadrenoleukodystrophy
AT kangjoonwon thegeneticallymodifiedpolysialylatedformofneuralcelladhesionmoleculepositivecellsforpotentialtreatmentofxlinkedadrenoleukodystrophy
AT kanghoonchul thegeneticallymodifiedpolysialylatedformofneuralcelladhesionmoleculepositivecellsforpotentialtreatmentofxlinkedadrenoleukodystrophy
AT jangjiho geneticallymodifiedpolysialylatedformofneuralcelladhesionmoleculepositivecellsforpotentialtreatmentofxlinkedadrenoleukodystrophy
AT kimhansoo geneticallymodifiedpolysialylatedformofneuralcelladhesionmoleculepositivecellsforpotentialtreatmentofxlinkedadrenoleukodystrophy
AT kangjoonwon geneticallymodifiedpolysialylatedformofneuralcelladhesionmoleculepositivecellsforpotentialtreatmentofxlinkedadrenoleukodystrophy
AT kanghoonchul geneticallymodifiedpolysialylatedformofneuralcelladhesionmoleculepositivecellsforpotentialtreatmentofxlinkedadrenoleukodystrophy